metformin and gw 501516

metformin has been researched along with gw 501516 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ1
Ding, J; Gou, Q; Hou, Y; Jin, J; Liu, Q; Shi, J1

Other Studies

2 other study(ies) available for metformin and gw 501516

ArticleYear
Identification of potent Yes1 kinase inhibitors using a library screening approach.
    Bioorganic & medicinal chemistry letters, 2013, Aug-01, Volume: 23, Issue:15

    Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship

2013
Metformin inhibits PPARĪ“ agonist-mediated tumor growth by reducing Glut1 and SLC1A5 expressions of cancer cells.
    European journal of pharmacology, 2019, Aug-15, Volume: 857

    Topics: Amino Acid Transport System ASC; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Glucose; Glucose Transporter Type 1; Glutamine; Humans; Metformin; Mice; Minor Histocompatibility Antigens; PPAR delta; Thiazoles; Transcription, Genetic; Xenograft Model Antitumor Assays

2019